trial · primary record
Empasiprubart IV
Chronic Inflammatory Demyelinating Polyneuropathy
| Phase | Phase 3 |
|---|---|
| Status | RECRUITING |
| Sponsor | Unknown |
| Enrolment | 160 |
| Primary completion | 2031-01-23 |
| Primary endpoint | Reduction of ≥1 point compared with baseline in aINCAT score at week 24 |
| Registry ID | NCT07091630 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-10-28T02:32:29.890Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT07091630
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.